1. Home
  2. INDP vs YQ Comparison

INDP vs YQ Comparison

Compare INDP & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

YQ

17 Education & Technology Group Inc.

HOLD

Current Price

$2.64

Market Cap

25.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
YQ
Founded
2000
2012
Country
United States
China
Employees
N/A
1017
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
25.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
INDP
YQ
Price
$1.14
$2.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
38.0K
8.5K
Earning Date
05-11-2026
06-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$1.70
52 Week High
$13.24
$6.45

Technical Indicators

Market Signals
Indicator
INDP
YQ
Relative Strength Index (RSI) 27.50 58.72
Support Level N/A $2.55
Resistance Level $2.08 $3.68
Average True Range (ATR) 0.23 0.30
MACD -0.11 0.03
Stochastic Oscillator 17.79 62.50

Price Performance

Historical Comparison
INDP
YQ

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is engaged in providing education and education technology services in the People's Republic of China (PRC) with a focus on the Teaching and Learning SaaS offerings. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.

Share on Social Networks: